Dry Eye

At our cutting - edge eye care practice, we are committed to providing innovative solutions for dry eye disease caused by meibomian gland dysfunction (MGD), a leading cause of dry eye symptoms. Our office proudly offers OptiLIGHT and OptiPLUS, FDA - approved technologies by Lumenis, designed to address the root causes of dry eye and deliver lasting relief for patients experiencing discomfort from MGD.

OptiLIGHT is the first and only FDA-approved intense pulsed light (IPL) therapy for themanagement ofdry eye disease due to meibomian gland dysfunction. Using patented Optimal Pulse Technology (OPT™), OptiLIGHT delivers precise, controlled pulses of broad-spectrumlight to the skin below the eyes. This non-invasive treatment targets inflammation, a keycontributor to MGD, by reducing abnormal blood vessels and promoting healthier meibomiangland function. The result is improved tear film quality, reduced dry eye symptoms such asburning, grittiness, and redness, and enhanced ocular comfort.

What to Expect with OptiLIGHT

• A series of four quick sessions (10-15 minutes each), spaced 2-4 weeks apart.

• Minimal discomfort, with a warm sensation during treatment.

• No downtime, allowing immediate return to daily activities.

• Noticeable improvement often reported after the second or third session.

OptiLIGHT is safe, effective, and clinically proven to address the underlying causes of dry eye,reducing dependency on artificial tears and other temporary solutions

To enhance the effectiveness of OptiLIGHT, our practice utilizes OptiPLUS, an FDA - cleared dual - frequency radiofrequency (RF) technology designed to complement OptiLIGHT therapy. OptiPLUS delivers targeted heat across various tissue layers to stimulate meibomian gland function and improve gland productivity. By promoting collagen production and enhancing blood circulation, OptiPLUS supports healthier gland morphology and further alleviates dry eye symptoms caused by MGD

Key Benefits of OptiPLUS

• Enhances meibomian gland function to improve tear film stability.

• Targets deeper tissue layers for comprehensive treatment.

• Works synergistically with OptiLIGHT for optimal results.

• Safe and comfortable, with treatments typically lasting 8 minutes per eye

​​​​​​​OptiPLUS is used in combination with OptiLIGHT to provide a comprehensive approach tomanaging dry eye disease, addressing both inflammation and gland dysfunction for long-termrelief.

If you’re struggling with dry, itchy, or burning eyes due to meibomian gland dysfunction, our advanced OptiLIGHT and OptiPLUS treatments offer a proven solution. Contact us today to schedule a consultation and discover how our FDA - approved dry eye therapies can restore your comfort and improve your quality of life.

Platelet - Rich Plasma (PRP) therapy is an innovative, regenerative treatment for dry eye disease (DED), a condition characterized by insufficient tear production or poor tear quality, leading to discomfort, irritation, and potential damage to the ocular surface. PRP therapy utilizes a patient’s own blood to create MYE Drop, a personalized eye drop rich in growth factors, cytokines, and vitamins that mimic natural tears. These components promote healing of the corneal and conjunctival epithelium, reduce inflammation, and improve symptoms of dry eye disease.

How MYE Drop Works
MYE Drop, a form of PRP eye drops, is crafted from a patient’s blood through a simple, safe process:

• Blood Draw: A small sample of blood is collected from the patient, similar to a routinelab test.

• Centrifugation: The blood is processed in a centrifuge to separate and concentrateplatelets and plasma, yielding a solution with 2.5 to 8 times the platelet concentration ofwhole blood.

• Preparation: The resulting PRP is extracted and dispensed into sterile eye drop bottles asMYE Drop.

• Application: Patients typically apply one drop four times daily in the affected eye(s) forthree months or as directed by their eye care provider.

This process, completed in under 45 minutes, ensures a natural, preservative-free treatmenttailored to the patient’s needs.

MYE Drop offers a cutting-edge approach to managing dry eye disease, particularly for patients unresponsive to conventional treatments like artificial tears or anti-inflammatory drops. Key benefits include:

• Natural and Safe: Derived from the patient’s own blood, MYE Drop minimizes the risk of allergic reactions or adverse effects.

• Promotes Healing: Rich in growth factors like platelet-derived growth factor and epidermal growth factor, MYE Drop supports tissue regeneration, heals corneal damage, and stabilizes the tear film.

• Reduces Inflammation: PRP contains anti-inflammatory agents that alleviate discomfort and reduce ocular surface inflammation.

• Effective for Severe Cases: Clinical studies show PRP therapy improves symptoms in moderate to severe DED, including evaporative, aqueous-deficient, neuropathic, and LASIK-induced dry eye. It also aids in healing corneal ulcers and reducing recurrent corneal erosions.

• Long-Lasting Relief: Unlike artificial tears, which provide temporary moisture, MYE Drop addresses the root causes of dryness, offering sustained relief.

While both MYE Drop (PRP) and autologous serum (AS) eye drops are blood-derived, MYE Drop is superior due to its higher concentration of platelets and growth factors. Autologousserum lacks platelets, which are removed during processing, resulting in lower levels of healing factors. Additionally, AS may contain inflammatory cytokines, potentially harmful in conditions like Sjögren’s syndrome. MYE Drop’s potent regenerative properties make it more effective for
tissue repair and symptom relief.

MYE Drop is ideal for patients with:

• Chronic dry eye disease unresponsive to traditional therapies.
• Conditions like Sjögren’s syndrome, post-LASIK dry eye, or neurotrophic keratitis.
• Corneal ulcers or recurrent corneal erosions requiring enhanced healing.

Approximately 85% of patients report improved dry eye symptoms with PRP therapy, makingMYE Drop a game-changer for those seeking relief

To determine if MYE Drop is right for you, schedule a comprehensive dry eye evaluation with Dr. Connor. Treatment is personalized, ensuring compatibility with your specific condition.

MYE Drop stands out as a natural, effective, and clinically validated option for dry eye disease. Its ability to harness the body’s own healing mechanisms offers a holistic alternative to artificial tears, which often provide only temporary relief. By addressing the underlying causes of DED, MYE Drop helps restore ocular health, reduce discomfort, and enhance quality of life.

For more information or to explore MYE Drop therapy, contact our office and we'll be happy to assist.